Change of Name

Recorded: 2023-07-17 Pages: 3

View PDF Order Certified Copy

Assignor

AURIGENE DISCOVERY TECHNOLOGIES LIMITED

Executed: 2022-12-07

Assignee

AURIGENE ONCOLOGY LIMITED

39-40(P), KIADB INDUSTRIAL AREA, ELECTRONICS CITY PHASE II HOSUR ROAD,, BANGALORE, KARNATAKA, 560100, INDIA

Covered Properties (5)

Protein Kinase Inhibitors

Patent: 9,447,091 →

Application: 14/350,718 →

Publication: US 2015/0011548

Protein Kinase Inhibitors

Patent: 10,391,082 →

Application: 15/973,020 →

Publication: US 2018/0250272

Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor

Patent: 10,870,637 →

Application: 16/495,865 →

Publication: US 2020/0102291

Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor

Patent: 11,332,460 →

Application: 16/953,468 →

Publication: US 2021/0139462

Novel Hydrochloride Salt Forms of a Sulfonamide Structured Kinase Inhibitor

Patent: 11,866,420 →

Application: 17/273,774 →

Publication: US 2021/0332028

Related Assignments (5)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Sep 10, 2014

From: LINNANEN, TERO; WOHLFAHRT, GERD; NANDURI, SRINIVAS; UJJINAMATADA, RAVI

To: ORION CORPORATION

Reel/Frame 033705/0823 →

Assignment of Assignor's Interest Jan 30, 2020

From: KARJALAINEN, OSKARI; PIETIKÄINEN, PEKKA

To: ORION CORPORATION

Reel/Frame 051671/0824 →

Assignment of Assignor's Interest Apr 21, 2022

From: KARJALAINEN, OSKARI; PIETIKÄINEN, PEKKA

To: ORION CORPORATION

Reel/Frame 059663/0214 →

Assignment of Assignor's Interest Sep 12, 2022

From: ORION CORPORATION

To: AURIGENE DISCOVERY TECHNOLOGIES LIMITED

Reel/Frame 061059/0650 →

Assignment of Assignor's Interest Oct 14, 2022

From: JONAITIS, DAVID; KARJALAINEN, OSKARI

To: ORION CORPORATION

Reel/Frame 061424/0154 →